Sun Pharmaceutical ... drug portfolio in its core areas of dermatology and ophthalmology. This comes at a time when the company’s generic business continues to face pricing pressure. The company’s ...
Over 50 schools have received bomb threats, according to Times Now report. DCP New Delhi, Devesh Kumar Mahla said, "As a ...
The Food and Drug Administration continues using import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates ...
Sun Pharmaceutical ... as one of India's top pharmaceutical companies. Notably, a subsidiary of the company recently received the USFDA’s (United States Food and Drug Administration) approval ...
With the approval of X4 Pharmaceuticals’ first product mavorixafor, there’s a new commercial rare disease player in town. Following a 10-year development journey, the FDA on Monday approved ...
In light of the elevated levels of active drug shortages in the United States, Indian pharmaceutical companies such as Aurobindo, Sun Pharmaceutical Industries, and Gland Pharma are projected to ...
The FDA's Endocrinologic and Metabolic Drugs Advisory ... In an interview with Fierce Pharma three years ago, Novo CEO Lars Fruergaard Jorgensen called the treatment a “revolution” in the ...
Sun Pharma Advanced Research Company Ltd share price was down by -4.99% from the previous closing price of ₹244.50. Who are peers of Sun Pharma Advanced Research Company Ltd? The peers of Sun ...
The Subject Expert Committee (SEC), that advises the Central drug regulator regarding clinical trials and approvals of drugs, has recommended for grant of approval for import and market of AstraZeneca ...
Glenmark Pharma Share Price Today NSE, BSE: Glenmark Therapeutics Inc, USA will distribute the drug in the US market, the drug maker said. The stock has been gaining for the last four days and is ...
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say ...
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say ...